Related references
Note: Only part of the references are listed.Mechanism of CFTR correction by type I folding correctors
Karol Fiedorczuk et al.
CELL (2022)
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
Mihaly Varadi et al.
NUCLEIC ACIDS RESEARCH (2022)
Inverse Molecular Docking Study of NS3-Helicase and NS5-RNA Polymerase of Zika Virus as Possible Therapeutic Targets of Ligands Derived from Marcetia taxifolia and Its Implications to Dengue Virus
Cristian Buendia-Atencio et al.
ACS OMEGA (2021)
Comprehensive Analysis of Chemical Structures That Have Been Tested as CFTR Activating Substances in a Publicly Available Database CandActCFTR
Manuel Manfred Nietert et al.
FRONTIERS IN PHARMACOLOGY (2021)
CFTR Lifecycle Map-A Systems Medicine Model of CFTR Maturation to Predict Possible Active Compound Combinations
Liza Vinhoven et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Review of CFTR modulators 2020
Danielle M. Goetz et al.
PEDIATRIC PULMONOLOGY (2021)
Inverse molecular docking reveals a novel function of thymol: Inhibition of fat deposition induced by high-dose glucose in Caenorhabditis elegans
Fangfang Ban et al.
FOOD SCIENCE & NUTRITION (2021)
A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
Anas Zaher et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
The future of cystic fibrosis care: a global perspective
Scott C. Bell et al.
LANCET RESPIRATORY MEDICINE (2020)
Cystic fibrosis in the year 2020: A disease with a new face
Kris De Boeck
ACTA PAEDIATRICA (2020)
An open-source drug discovery platform enables ultra-large virtual screens
Christoph Gorgulla et al.
NATURE (2020)
Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators
Gert de Wilde et al.
FRONTIERS IN PHARMACOLOGY (2019)
High-Throughput Screening for Modulators of CFTR Activity Based on Genetically Engineered Cystic Fibrosis Disease-Specific iPSCs
Sylvia Merkert et al.
STEM CELL REPORTS (2019)
High-Throughput Surface Liquid Absorption and Secretion Assays to Identify F508del CFTR Correctors Using Patient Primary Airway Epithelial Cultures
Allison Berg et al.
SLAS DISCOVERY (2019)
High Impact: The Role of Promiscuous Binding Sites in Polypharmacology
Natacha Cerisier et al.
MOLECULES (2019)
CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation
Xia Hou et al.
FASEB JOURNAL (2019)
Improving inverse docking target identification with Z-score selection
Stephanie S. Kim et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Patients With Cystic Fibrosis Have New Triple-Drug Combination
Rebecca Voelker
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
What Makes a Kinase Promiscuous for Inhibitors?
Sonya M. Hanson et al.
CELL CHEMICAL BIOLOGY (2019)
Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and Correctors
Kenneth A. Giuliano et al.
SLAS DISCOVERY (2018)
Ion Channel Modulators in Cystic Fibrosis
Martina Gentzsch et al.
CHEST (2018)
Discovery of 4-[(2R,4R)-4-({[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic Acid (ABBV/GLPG-2222), a Potent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Corrector for the Treatment of Cystic Fibrosis
Xueqing Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent
Steven E. Van der Plas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds
Hongbin Huang et al.
FRONTIERS IN CHEMISTRY (2018)
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Guido Veit et al.
NATURE MEDICINE (2018)
Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis
Kevin W. Southern et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration
Nafisa M. Hassan et al.
SCIENTIFIC REPORTS (2017)
High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations
Feng Liang et al.
SLAS TECHNOLOGY (2017)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
Cystic fibrosis: a model system for precision medicine
Stacey L. Martiniano et al.
CURRENT OPINION IN PEDIATRICS (2016)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening
Rodrigo Quiroga et al.
PLOS ONE (2016)
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking
Graeme W. Carlile et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ChEMBL web services: streamlining access to drug discovery data and utilities
Mark Davies et al.
NUCLEIC ACIDS RESEARCH (2015)
Potentiators of Defective ΔF508-CFTR Gating that Do Not Interfere with Corrector Action
Puay-Wah Phuan et al.
MOLECULAR PHARMACOLOGY (2015)
Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2
Tae-Gyu Lim et al.
CANCER PREVENTION RESEARCH (2014)
Biosynthesis of cystic fibrosis transmembrane conductance regulator
Iwona M. Pranke et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise
David Ryan Koes et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Patrick R. Sosnay et al.
NATURE GENETICS (2013)
InChI in the wild: an assessment of InChIKey searching in Google
Christopher Southan
JOURNAL OF CHEMINFORMATICS (2013)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
Inverse Virtual Screening of Antitumor Targets: Pilot Study on a Small Database of Natural Bioactive Compounds
Gianluigi Lauro et al.
JOURNAL OF NATURAL PRODUCTS (2011)
The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to facilitate RMA1 E3-dependent degradation of nascent CFTRΔF508
Diane E. Grove et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Activation of the Cystic Fibrosis Transmembrane Conductance Regulator by the Flavonoid Quercetin Potential Use as a Biomarker of ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Rescue
Louise C. Pyle et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The prevalence of cystic fibrosis in the European Union
Philip M. Farrell
JOURNAL OF CYSTIC FIBROSIS (2008)
Endocytic trafficking of CFTR in health and disease
Nadia Ameen et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator
J. Michael Younger et al.
CELL (2006)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Equol, a natural estrogenic metabolite from soy isoflavones:: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta
RS Muthyala et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening
JL Bobadilla et al.
HUMAN MUTATION (2002)
Share Paper
